CannabisNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Announces Additional $10M Investment in TerrAscend Canada Inc.

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced completion of a US$10 million investment in TerrAscend Canada Inc., a subsidiary of its portfolio company TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF). According to the update, the investment includes the purchase of 13,243 units, with each consisting of one unsecured convertible debenture of TerrAscend Canada with a principal amount of C$1,000 and 25.2 common share purchase warrants of TerrAscend exercisable until October 2, 2024. TerrAscend is the first and only cannabis company with sales in Canada, the U.S. and Europe with an international portfolio that includes a robust research and development platform, domestic and international cultivation, processing, distribution facilities, and medical and adult-use branded cannabis products. “We think TerrAscend is uniquely positioned to meet the evolving consumer demands in the three largest cannabis markets worldwide,” Canopy Rivers President and CEO Narbe Alexandrian said in the news release. “We strongly believe in TerrAscend’s ability to execute on its global strategy, market a diversified brand portfolio, and build on its recent acquisitions, and this additional investment is an affirmation of that belief.”

To view the full press release, visit http://cnw.fm/XmI1W

About Canopy Rivers Inc.

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers identifies strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth Corporation (TSX: WEED, NYSE: CGC) and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire ecosystem. For more information, visit the company’s website at www.CanopyRivers.com.

NOTE TO INVESTORS: The latest news and updates relating to CNPOF are available in the company’s newsroom at http://cnw.fm/RIV

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – A New Study Aims to Find if Marijuana Can be Used to Treat Symptoms of Autism

Montefiore Medical Center in New York is conducting a clinical trial which will examine the effects of cannabidivarin (CBDV) on the level of irritation and repetitive behaviors in autistic children. Cannabidivarin is a compound of marijuana that is nonpsychoactive and does not induce highness upon consumption.

GW Pharmaceuticals grows the cannabis to be used during the research. The company occupies 47-plus acres in the English countryside and is the first drug company to develop cannabis-related medicine which was approved by the U.S. Food and Drug Administration. Two rare types of epilepsy are treated using the drug.

Dr Sanjay Gupta, who is a CNN Chief Medical Correspondent, got exclusive access to the clinical trials In Montefiore Medical Center and GW Pharmaceuticals company.

While reporting for Weed 5 on the cannabinoid craze, Gupta had an exclusive look at GW cannabis greenhouses. The greenhouses occupy the 47 acres allowing for consistent breeding of different strains of the marijuana crop for medicine. According to David Cooper, head of manufacturing in the company, the process of developing and mastering different strains of the cannabis plant is challenging. During the tour, David showed Gupta the process of turning different strains of the plant into medicine for the large pool of patients.

Gupta also found that GW Pharmaceuticals has been in operation for the last 20 years. Moreover, towards the end of 2018, the company launched Epidiolex.

Epidiolex is the first cannabis-related oral medication to be approved by the FDA. It is used for treating two rare epilepsy disorders. During the clinical trials, Epidiolex reduced the severity of seizure in patients with Dravet Syndrome by an average of 45%-50%. Epidiolex is made of cannadidiol, which is an extracted compound of the cannabis plant.

Epidiolex’s success in treating epilepsy motivated GW Pharmaceutical to manufacture another cannabis-based drug for treating people with a neurological disorder known as autism. Epilepsy and autism have similar symptoms such as loss of cognitive function, poor language skills, and poor socialization skills.

The Director of the AOCD (Autism and Obsessive Compulsive Spectrum, Anxiety and Depression) Program at Montefiore Hospital, Dr Eric Hollander, gets CBDV (cannabidivarin) from GW Pharmaceuticals in UK for the clinical trials. Based on the success of CBDV to reduce seizures, he believes that the hope for treating autism symptoms is in the extract.

Hollander further says that CBDV could help in reducing aggression, self-injury or temper tantrums in autist patients. The clinical trials are headed by Hollander who has 30 years’ experience researching autism. According to Hollander, autism and epilepsy have simiar symptoms.

Autism has no cure. Therefore, Hollander’s focus is on treating the underlying causes of autism, and use of CBDV could help remedy the symptoms.

When CBDV was administered in animals having similar symptoms to autism, the researchers saw that it had significant effect on social functioning, increased cognitive function, less seizures and a reduction in compulsive and repetitive behaviors, thus their application of CBDV on autistic patients.

The clinica trials involve 100 participtants, who are aged between 5-18 years. The treatment takes 12 weeks and will be finalized in September 2021.

It is widely expected that marijuana industry players like IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) and Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) will be eager to learn the outcomes of this autism research.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Five Reasons Medical Marijuana is Overshadowing Recreational Marijuana in the Market

The cannabis industry has created a buzz on Wall Street over the years. This is attributed due to the increased potential of legal marijuana.

Arcview Market Research and BDS Analytics released a report on the state of legal marijuana market, which shows that between the year 2014 and 2018, global sales of legal weed in licensed stores tripled. After investing in the weed industry Wall Street is predicting that on the lower side, annual sales will be $50 billion or $200 billion on the higher side in the next ten years. If their estimate is correct, the marijuana sector will 2 or 2.5 times larger than the soda beverage industry. With this kind of growth, it would be foolish for the investors and Wall Street not to take advantage of the opportunity.

When purchasing cannabis stocks, you have to consider several variables such as supply deals and partnerships as well as the geographical focus.

The report further suggests that recreational marijuana sales all over the world in the year 2024 will be almost double that of medical marijuana. Countries such as Mexico will legalize personal use of marijuana, and this is bound to surpass the medical marijuana sales because patients will see no reason to pay doctors’ consultation fees to access medical cannabis when they can go to the dispensary and buy it.

Although most people are investing in recreational marijuana, it would be wise if people paid more attention to medical marijuana. Discussed below are the five reasons why you should focus more on medical marijuana

Patients Tend to Buy and Use Medical Cannabis Often

Pot stocks are popular among medical marijuana patients. In the last quarter of 2018, surveys carried out in Canada showed that medical cannabis patients buy and use cannabis more often, while people do not purchase or use recreational marijuana as often.

Medical Marijuana Has Higher Margins

Compared to recreational users, medical marijuana consumers tend to consume products with higher margins for the sellers of cannabis products. This is because patients are willing to purchase medical marijuana products such as beverages, edibles, oils, concentrates or vapes with a higher profit margin, while recreational marijuana is in the form of dried weed that has low margins and consumers fear to overdose.

Probability of a Broader Global Market

Over the next ten years, medical marijuana may be explode on the global market; therefore, investors should start investing in the industry. There will be three recreational marijuana markets worldwide if Mexico legalizes marijuana for personal use in October. In the coming years, the future of the pot industry is in medical cannabis which is being accepted in more jurisdictions worldwide.

Appeals to the Younger Generation

Medical marijuana connects with young adults in a quick manner. The ability to buy marijuana derivatives by the younger generation has resulted in dried weed avoidance. The younger generation consumes large amounts of marijuana; therefore, they are expected to be the driving force of the pot industry.

Medical Marijuana Gives Traction to CBD

Through the medical marijuana industry, CBD (cannabidiol), which is a nonpsychoactive cannabinoid that has many medical benefits, gains a paramount degree of exposure. This explosure opens new revenue streams for medical marijuana companies.

Experts think that these five reasons could explain why many marijuana companies, such as Green Hygienics Holdings Inc. (OTCQB: GRYN) and HTC Extraction Systems (TSX.V: HTC) have an eye on the medical marinuana segment.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsBreaks – GP Solutions, Inc.’s (GWPD) Co-Branded Snoop Dogg Product Line a Hit at CannaCon South

GP Solutions (OTC: GWPD), the developer of highly innovative automated micro-farms trade named “GrowPods,” premiered its new co-branded “Snoop’s Premium Nutrients Pods” at the recent CannaCon South show in Oklahoma City. According to the update, Snoop Dogg, a longtime legal cannabis advocate, developed his product line to offer a quality system that encourages rapid, robust growth throughout all stages of plant development. “Our Snoop’s Premium Nutrients Pods were the hit of the show,” GP Solutions CEO George Natzic said in the news release. “Not only was the interest level incredibly high, but we are also in the process of closing multitudes of deals.”

To view the full press release, visit http://cnw.fm/MHx4v

About GrowPod

GrowPod, Inc. is the developer of highly innovative automated micro-farms trade named “GrowPods.” GrowPods are a modular, stackable and mobile vertical growing environment specifically engineered to maximize yield and automation. Offering fully insulated, food-grade shipping container that has been specifically modified to provide the optimum controlled environment for growing a wide range of horticultural and agricultural products in all environments and climates. With the company’s combination of hydroponic and certified organic soil systems, clients can produce a significantly higher yield that grows faster, healthier and more consistent. For more information, visit the company’s website at www.GrowPodSolutions.com.

NOTE TO INVESTORS: The latest news and updates relating to GWPD are available in the company’s newsroom at http://cnw.fm/GWPD

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsBreaks – Youngevity International Inc. (NASDAQ: YGYI) Announces Dividend Payment Timing for September 2019 Series “D” Cumulative Redeemable Perpetual Preferred Stock

Youngevity International (NASDAQ: YGYI), a leading multi-channel lifestyle company operating in three distinct business segments, today announced the timing for the payment of its declared regular monthly dividend of $0.203125 per share of its 9.75% Series D Cumulative Redeemable Perpetual Preferred Stock (NASDAQ:YGYIP) for September 2019. According to the update, the dividend will be payable on October 15, 2019, to holders of record as of September 30, 2019, and will be paid in cash.

To view the full press release, visit http://cnw.fm/4yYFY

About Youngevity International Inc.

Youngevity International Inc. is a multi-channel lifestyle company operating in three distinct business segments, including a commercial coffee enterprise, a commercial hemp enterprise and a multi-vertical omni direct selling enterprise. The company features a multi country selling network and has assembled a virtual Main Street of products and services under one corporate entity. YGYI offers products from the six top-selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry and innovative services. For more information, visit the company’s website at www.YGYI.com

NOTE TO INVESTORS: The latest news and updates relating to YGYI are available in the company’s newsroom at http://cnw.fm/YGYI

About CannabisNewsWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Cannabis Expo in West Michigan Set to Educate Consumers and Businesses about the Marijuana Industry

The WMCE (West Michigan Cannabis Expo) will be all things marijuana. It is a two-day event, that will be held at DeltaPlex Arena in Grand Rapids. The event which will be having 60 booths plus is a perfect opportunity for consumers, businesses and other professionals in the cannabis industry to showcase their products and services. It is also an avenue for learning more about the marijuana industry.

The expo also aims to help businesses to develop new leads, strengthen their relationship with their clients and customers, and market their organization.

Some of those who will be in attendance include a hemp product company, cannabinoids retailers, equipment retailers, consumers and growers, as well as legal and accounting professionals.

The WMCE commences on Saturday 5^th October. The event opens at 10 a.m and will end at 5 p.m. October 6^th is the last day of the expo, and it will be open from 10 a.m to 4 p.m at the DeltaPlex Arena.

DeltaPlex director of events development, Chris Hudson says that business-oriented people expected to attend the event are about 60 percent while the remaining 40 percent comprises of cannabis consumers and people who would like to learn more about the industry.

In November 2018, Michigan legalized marijuana for personal use while medical marijuana was legalized in 2008. The legislation governing recreational marijuana provides that you must be 21 years or older to purchase, use or cultivate marijuana.

According to Hudson, the WMCE was organised after significant growth was observed that in the sector since the legalization of recreational marijuana as people from other states came to Michigan to get their fix. More so, businesses and individuals seeking to join the industry have many questions, and the Expo would help answer and educate them on how to join the marijuana industry. The expo would also help them gain resources such as machines required to make and extract marijuana products.

During the expo, there will be cannabis-cooking demonstrations, seminars on marijuana licensing and banking with cannabis, cannabis medicines displays, and extracts.

The cost of a ticket is $15 for one day, but if you want to attend both days, you will have to pay $25. There is also an upgraded ticket that costs $50, which allows you to participate in a mixer on Saturday at 5.30 p.m. The mixer is for adults who are 21 years and above.

THC products are not allowed into the expo because the state will accept recreational business applications in November.

Analysts are of the view that industry players like Grapefruit Boulevard Investments Inc. (OTCQB: IGNG) and Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) are happy that such events are being organized to bring marijuana into the mainstream.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Lower Doses of Marijuana may be more Effective in Improving Libido

Weed budtenders’ advice to new marijuana users is to start slow and go slow on marijuana. This ensures that they do not overdose and they are responsible for their usage. The budtenders’ mantra is the topic of discussion in a new paper that reviews currents studies on sex and how it is affected by marijuana consumption.

Research on the effects of marijuana have been taking place over the years, and according to the review authors, most of the studies suggest that desire is affected by the level of dosage. The studies indicate that consuming lower doses of marijuana improves your desire. However, when consumers indulged in high doses, their longing decreased or wasn’t affected by the weed.

Researches on the effects of marijuana support the view that cannabis positively affects sexual desire as it results in heightened libido and better orgasms, but, due to legal restrictions, quality studies on cannabis are few. The authors also analyze what the current studies show about the effect of cannabinoid on female sexual longing; and published their findings in this month’s edition of Sexual Medicine Review.

According to the review, most of the studies concluded that marijuana has a positive effect on animal and human sexual pleasure. Use of marijuana during or before sex helps by increasing sexual desire, and brings prolonged and better orgasms. Of all the studies analyzed and reviewed, only one study showed that marijuana inhibits orgasm. This is because the research was focused on the adverse effects of cannabis instead of the general function.

The review authors analyzed 12 studies on human beings and eight studies on animals that were published in the years 1970-2019.

In their review involving animals, they found that when THC was administered to female hamsters with high levels of oestrogen, their desire to mate was heightened and the likelihood of approaching male hamsters for mating was high. This was not observed in Hamsters that were not given THC.

In another study, rats with detectable levels of oestrogen and progesterone were given THC, which enhances lordosis. Lordosis is a position where the rat is arching its back down. Lordosis is used to assess sexual motivation in female rats. When high doses of THC were administered in the rats, their longing was reduced. Other products of marijuana used were endocannabinoid receptor agonists and antagonists. These included anandamide and SR141716. When rats were given anandamide, their desire to mate was increased, but when they were given SR141716, their desire reduced.

Their analysis of studies involving human beings found that more women experienced increased desire than men when they consumed weed. In 1974, a study involving college students found that 57.8% of the women experience increased desire while 39.1% represented the male students. The same study also suggested that the longing was dependent on the amount of marijuana consumed. When they smoked one joint, their desire increased, but when they consumed more, the desire lessened. The lessened longing is associated with the sleeping effect of marijuana.

A study carried out in India and Nepal had the same findings, where the amount of marijuana consumed affects sex. It also concluded that frequent consumption of weed increased the probability of experiencing satisfactory orgasms.

In conclusion, the review authors wrote that it is important to understand how women’s sexual longing is affected by cannabinoids because it would help in developing better therapeutic options and better understand female sexual functioning. The analysis was more dependent on rodent research and questionnaires since human studies do not indicate the exact dosage or time.

Analysts believe that marijuana industry companies like Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) and GP Solutions Inc. (OTC: GWPD) aren’t surprised by the findings of this review since the effects of marijuana on libido have been known for long.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsBreaks – SinglePoint Inc. (SING) Realizes Impressive Revenue Growth in Q2 2019

Technology and investment company SinglePoint (OTCQB: SING) recently reported significant revenue earnings during second quarter 2019. An article discussing the company reads, “SinglePoint filed Form 10-Q for the quarterly period ended June 30, 2019. The company more than doubled its revenue from the same period the year prior; revenue increased from $311,237 in 2018 to $856,859 in 2019 (http://cnw.fm/zPD2V). . . . ‘We are very excited about the growth and path we are on,’ SinglePoint president Wil Ralston stated in a news release. ‘This is another step in the right direction for SinglePoint. We look forward to showing an even larger increase in Q3 as we will have the addition of Direct Solar projects that have closed and been funded. Everyone in the company has done a wonderful job, and it’s showing in the growth of revenue and number of opportunities being presented.’”

To view the full article, visit http://cnw.fm/tsN0b

About SinglePoint Inc.

SinglePoint is a technology and investment company with a focus on acquiring companies that will benefit from the injection of growth capital and technology integration. The company portfolio includes mobile payments, ancillary cannabis services and blockchain solutions. Through acquisitions into horizontal markets, SinglePoint is building its portfolio by acquiring an interest in undervalued companies, thereby providing a rich, diversified holding base. Through SingleSeed, the company is providing products and services to the cannabis industry. For more information, visit the company’s website at www.SinglePoint.com.

NOTE TO INVESTORS: The latest news and updates relating to SING are available in the company’s newsroom at http://cnw.fm/SING

About CannabisNewsWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsBreaks – IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) Reports Q2 Revenues Up 377%

IONIC Brands (CSE: IONC) (OTC: IONKF) (FRA: IB3), a West Coast cannabis holding company specializing in the recreational adult-product market, recently announced impressive second-quarter financial results. An article discussing the company reads, “IONIC saw a year-over-year increase of 377% in sales for the period ended June 30, leaving the company $3.86 million better than the prior year. The sales increase was largely due to an increase in services, packaging and ancillary products to its customers and their downstream sales, as well as an increase in licensing and equipment rental revenue to those customers. Two acquisitions also played into the revenue picture. . . . ‘We are very pleased with our second-quarter financial results, achieving our focus of increasing sales growth while closing a successful financing for various strategic business acquisitions all in a span of three months,’ chairman and CEO John Gorst stated in an August 29 news release announcing the results (http://cnw.fm/UK5fN).”

To view the full article, visit http://cnw.fm/P9pkc

About IONIC Brands Corp.

IONIC Brands is focused on building a multistate, consumer-focused, cannabis-concentrate brand portfolio focusing on the premium and luxury segments. The cornerstone brand of the portfolio, IONIC, is one of the top vaporizer brands in Washington State and has aggressively expanded throughout the West Coast of the United States. The brand is currently operating in Washington, Nevada, Oregon and California. IONIC Brands strategy is to be the leader of the highest-value segments of the cannabis market and expand nationally. For more information, visit the company’s website at www.IONIC.social.

NOTE TO INVESTORS: The latest news and updates relating to IONKF are available in the company’s newsroom at http://cnw.fm/IONC

About CanadianCannabisWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CBDNewsBreaks – ChineseInvestors.com Inc. (CIIX) Announces CBD Biotech, Inc.’s Expansion with Products Now Available In Seven New Major Asian Markets

Established financial news and investment portal for the global Chinese-speaking community ChineseInvestors.com (OTCQB: CIIX) today announced expansion of its subsidiary, CBD Biotech, Inc., into six new countries and a new region of China via Shopee, its newest sales channel. Shopee, which launched in 2015, is now the largest e-commerce platform in Southeast Asia with more than 4 million registered businesses, 200 million app downloads, 30 million social media fans and over 7 million active buyers. Southeast Asia’s e-commerce market is expected to reach $240 billion by 2025 according to Google and Temasek’s Southeast Asia Internet Economy Report. “This dynamic and very popular platform in Southeast Asia, has allowed CBD Biotech to execute on our plans for expansion throughout Asia,” CBD Biotech Chief Financial Officer Alex Hamilton said in the news release. “Thanks to Shopee, we are now in seven new major markets: Singapore, Malaysia, Thailand, Indonesia, Vietnam, Philippines and Taiwan, China.”

To view the full press release, visit http://cnw.fm/K3M2j

About ChineseInvestors.com

Founded in 1999, ChineseInvestors.com endeavors to be an innovative company providing: (a) real-time market commentary, analysis and educational-related services in Chinese language character sets (traditional and simplified); (b) advertising and public relations-related support services; and (c) retail, online and direct sales of hemp-based products and other health and wellness products. For more information, visit the company’s website at www.ChineseInvestors.com.

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://cnw.fm/CIIX

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com